[Primary prevention of chronic non-communicable diseases and acetylsalicylic acid: ambiguity of opinions].
Kardiologiia
; 60(3): 96-101, 2020 Mar 18.
Article
em Ru
| MEDLINE
| ID: mdl-32375621
ABSTRACT
Chronic noninfectious diseases (cardiovascular, bronchopulmonary, oncological diseases and diabetes mellitus) are presently the most common cause of death worldwide, with cardiovascular diseases (CVD) being predominant. For this reason, the key goal of a physician is not only to treat but also to prevent diseases. Acetylsalicylic acid (ASA) is considered one of the most effective drugs for secondary prevention of CVD. However, the use of ASA for primary prevention is still debated. Results of many studies of ASA are inconsistent. Some studies have suggested that using ASA in patients aged 40-70 with a high 10-year risk of CVD and a low risk of bleeding may reduce the incidence of CVD. Administration of ASA to patients with a high or medium risk of CVD is also considered.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doenças Cardiovasculares
/
Aspirina
/
Doenças não Transmissíveis
Limite:
Adult
/
Aged
/
Humans
/
Middle aged
Idioma:
Ru
Revista:
Kardiologiia
Ano de publicação:
2020
Tipo de documento:
Article